NCT02463539View on ClinicalTrials.gov

Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

August 31, 2016

Conditions
Pneumococcal InfectionANCA-associated Vasculitis
Trial Locations (1)

75014

AP-HP ; Cochin Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02463539 - Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis | Biotech Hunter | Biotech Hunter